Skip to main content
. Author manuscript; available in PMC: 2021 Sep 8.
Published in final edited form as: Mol Pharm. 2020 Jul 24;17(9):3270–3280. doi: 10.1021/acs.molpharmaceut.0c00390

Fig. 4.

Fig. 4

PXRD patterns of formulations, SFD L-leucine, raw materials and PM (A); PXRD patterns of above materials without displaying L-leucine and PM (B). SFD L-leucine data are reprinted from Yu et al.46 with permission.